GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $0.620 0 %
High/ Low $0.620 - $0.620 0%
Chg 7 Days N/A $0.620 $0.620
Chg 30 Days N/A $0.620 $0.620
Chg 12 mos -76.79 % $2.67 $0.620
Trend - 3 mos -0.290 % Width: 3.28 %
Trend - 12 mos -82.64 % Width: 449.33 %
Pred. range - 3 mos $0.616 - $0.636 -0.582 % - 2.68 %
Pred. range - 12 mos N/A - $0.0946 -100.00 % - -84.74 %
Short MA avg 3 mos Sell 0000-00-00 - N/A days
Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short/Long MA avg 3 mos Sell 0000-00-00 - N/A days
Short MA avg 12 mos Buy 2022-02-08 - 77 days
Long MA avg 12 mos Sell 2021-06-17 - 240 days
Short/Long MA avg 12 mos Sell 2021-06-24 - 235 days
Pivot Short Buy 2022-03-01 - 63 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Cesca Therapeutics Inc.

Cesca Therapeutics. Cesca Therapeutics Inc. focuses on the research, development, and commercialization of autologous cell-based therapeutics for use in regenerative medicine in the United States and internationally. The company develops and manufactures automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. Its products include SurgWerks system, a proprietary system comprised ... KOOL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT